Evaluation of the Effectiveness of Standard and Innovative Products That Represent a Substitute Meal for Weight Management in a Reduction Diet in Obese Participants With Asthma
NCT05980663 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2023-08-08
Summary
Randomized stratified controlled clinical study for evaluate the effectiveness of a diet program designed for reduce body weight through standard and innovative products that are a substitute meal for weight management in a reduction diet in obese participants with asthma.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Meal replacement product- STANDARD PRODUCT
standard product line contains common ingredients and this type of product already exists on world markets
- DIETARY_SUPPLEMENT
-
Meal replacement product- INNOVATIVE PRODUCT
innovative product line contains raw materials that are considered better sources of potentially bioactive components
Sponsors & Collaborators
-
Belupo
collaborator OTHER -
Podravka d.d.
collaborator UNKNOWN -
Children's Hospital Srebrnjak
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-17
- Primary Completion
- 2023-09-30
- Completion
- 2023-12-31
Countries
- Croatia
Study Locations
More Related Trials
-
Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients
NCT01197794 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
NCT02513160 ·Status: COMPLETED ·Phase: PHASE3
-
Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma
NCT03762395 ·Status: RECRUITING ·Phase: PHASE2
-
Moderate to Persistent Asthma in the Obese Subject
NCT01016847 ·Status: TERMINATED ·Phase: PHASE4
-
A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge
NCT01299467 ·Status: WITHDRAWN ·Phase: PHASE1
-
Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications
NCT00557180 ·Status: COMPLETED
-
The Effect of Montelukast on Asthma Control in Overweight/Obese Atopic Asthmatics
NCT01329939 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Benralizumab Added to High-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
NCT01928771 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557
NCT01462617 ·Status: COMPLETED ·Phase: PHASE1
-
Nutrition for Asthmatics
NCT06151405 ·Status: RECRUITING ·Phase: NA
-
A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma
NCT02567708 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot of Lifestyle and Asthma Intervention
NCT03291808 ·Status: COMPLETED ·Phase: NA
-
Characterisation of Asthma in Obese Subjects
NCT00532831 ·Status: COMPLETED
-
Effect of Medical Food on Reducing Asthma Symptoms in Asthmatic Children
NCT01087710 ·Status: COMPLETED ·Phase: PHASE2
-
A Study To Estimate The Relative Bioavailability Of PF-00258210 Administered Alone Or In Combination With PF-00610355
NCT01043276 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma
NCT01365533 ·Status: COMPLETED ·Phase: PHASE2
-
A Long-term Study of Ba253BINEB in Patients With Bronchial Asthma
NCT02182661 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Benralizumab Added to Medium-dose Inhaled Corticosteroid Plus LABA in Patients With Uncontrolled Asthma
NCT01947946 ·Status: TERMINATED ·Phase: PHASE3
-
GSK2190915 Neutrophilic Asthma Study
NCT01471665 ·Status: COMPLETED ·Phase: PHASE2
-
Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma
NCT00573222 ·Status: COMPLETED
-
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
NCT02031640 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness and Efficiency of Mobile Technology in Disease Control of Asthmatic Obese Patients
NCT03964740 ·Status: UNKNOWN ·Phase: NA
-
A Pilot and Feasibility Study of Mobile-Based Asthma Action Plans
NCT01514760 ·Status: COMPLETED ·Phase: NA
-
Assessment of PFT, Safety, and PK of Zileuton Injection in Asthma Patients
NCT00534625 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma
NCT06502366 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3